Elixir Pharmaceuticals Company
Elixir Pharmaceuticals is a pharmaceutical company focused on the discovery, development and commercialization of novel pharmaceuticals for the treatment of metabolic diseases such as diabetes and obesity. The Company's scientific founders identified that interactions between specific genes and enzymes can slow the aging process, and they are developing compounds that stimulate these interactions and will be used to treat a range of diseases of aging, including metabolic disease.
Number Of Exists:
Series D
Industry:
Others
Last Funding Type:
Series D
Funding Status:
Late Stage Venture
Estimated Revenue:
Less than $1M
Total Funding:
$98.5M
Investors Number:
9
Headquarters:
United States
Technology:
Geroscience
Investor Type:
Company
Founded Date:
1999-01-01
Employee Number:
11-50